A Randomized, Multicentre, Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Clinical trial NCT07768189 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07768189
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-20
- Primary completion
- 2027-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.